Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/47723
Title: | Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities | Authors: | Ulutaş, Firdevs Bozdemir, Aslı Çelikyürek, Nevzat Atalay Albayrak Yaşar, Canan Çobankara, Veli |
Keywords: | co-morbid disease cut-off gout hyperuricemia allopurinol febuxostat uric acid adult age Article cardiovascular disease chronic kidney failure cohort analysis comorbidity controlled study cross-sectional study diabetes mellitus disease association drug use female follow up gender gout human hyperlipidemia hypertension hyperuricemia major clinical study male middle aged nephrolithiasis observational study prediction receiver operating characteristic risk factor sensitivity and specificity Turk (people) Turkey (republic) uric acid blood level |
Publisher: | Greek Rheumatology Society and Professional Association of Rheumatologists | Abstract: | Objective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout. Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ?7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%). Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease. © 2021 | URI: | https://doi.org/10.31138/mjr.32.3.243 https://hdl.handle.net/11499/47723 |
ISSN: | 2459-3516 |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu |
Files in This Item:
File | Size | Format | |
---|---|---|---|
CutOff-Value-of-Serum-Uric-Acid-for-Development-of-Gout-Disease-in-Patients-with-Multiple-CoMorbiditiesMediterranean-Journal-of-Rheumatology.pdf | 947.47 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
1
checked on Oct 13, 2024
Page view(s)
50
checked on Aug 24, 2024
Download(s)
24
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.